Featured Research

from universities, journals, and other organizations

No Evidence That Insoles Prevent General Back Pain

Date:
October 18, 2007
Source:
John Wiley & Sons, Inc.
Summary:
There is strong evidence that using insoles does not prevent people from getting nonspecific back pain, and there is insufficient evidence to say whether or not they help solve existing low-back pain, a Cochrane Systematic Review has found.

There is strong evidence that using insoles does not prevent people from getting non-specific back pain, and there is insufficient evidence to say whether or not they help solve existing low-back pain, a Cochrane Systematic Review has found.

Back pain is one of the most common health problems in the industrialised world. It comes second only to upper respiratory infection as a reason for people to visit a doctor in the USA. Up to 85% of people in the USA suffer from back pain at one point in their lives.

Some people have suggested that insoles in shoes might help by absorbing shock, keeping the foot more stable as it touches the ground and helping the person's walking action to become more stable and fluent.

A team of Cochrane Researchers searched the international literature for relevant studies and found six randomised controlled trials that met their inclusion criteria. These involved over 2300 participants. The researchers came to two main conclusions:

  1. there is strong evidence that the use of insoles does not prevent back pain in someone who does not have it already, and,
  2. there is limited evidence that using insoles may reduce back pain in people who have pain -- but it may also shift the pain from the back to the legs.

"We do need some good studies of the effect of insoles on existing or recurrent back pain, so that we can make recommendations with a greater sense of certainty," says lead researcher Dr Tali Sahar who works at the Department of Family Practice at the Hebrew University, Jerusalem, Israel.


Story Source:

The above story is based on materials provided by John Wiley & Sons, Inc.. Note: Materials may be edited for content and length.


Cite This Page:

John Wiley & Sons, Inc.. "No Evidence That Insoles Prevent General Back Pain." ScienceDaily. ScienceDaily, 18 October 2007. <www.sciencedaily.com/releases/2007/10/071016195925.htm>.
John Wiley & Sons, Inc.. (2007, October 18). No Evidence That Insoles Prevent General Back Pain. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2007/10/071016195925.htm
John Wiley & Sons, Inc.. "No Evidence That Insoles Prevent General Back Pain." ScienceDaily. www.sciencedaily.com/releases/2007/10/071016195925.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins